Cargando…
Anti-Retroviral Protease Inhibitors Regulate Human Papillomavirus 16 Infection of Primary Oral and Cervical Epithelium
SIMPLE SUMMARY: In 2016, globally, 36.7 million people were living with Human Immunodeficiency Virus (HIV), of which 53% had access to anti-retroviral therapy (ART) (UNAIDS 2017 Global HIV Statistics). The risk of Human Papillomavirus (HPV) associated oropharyngeal, cervical and anal cancers are hig...
Autores principales: | Alam, Samina, Chatterjee, Sreejata, Kang, Sa Do, Milici, Janice, Biryukov, Jennifer, Chen, Han, Meyers, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563395/ https://www.ncbi.nlm.nih.gov/pubmed/32961945 http://dx.doi.org/10.3390/cancers12092664 |
Ejemplares similares
-
UVC radiation as an effective disinfectant method to inactivate human papillomaviruses
por: Meyers, Craig, et al.
Publicado: (2017) -
The ability of two chlorine dioxide chemistries to inactivate human papillomavirus‐contaminated endocavitary ultrasound probes and nasendoscopes
por: Meyers, Craig, et al.
Publicado: (2020) -
Differentiation-Dependent Interpentameric Disulfide Bond Stabilizes Native Human Papillomavirus Type 16
por: Conway, Michael J., et al.
Publicado: (2011) -
Papillomavirus Infectious Pathways: A Comparison of Systems
por: Biryukov, Jennifer, et al.
Publicado: (2015) -
Retroviral proteases
por: Dunn, Ben M, et al.
Publicado: (2002)